News | Women's Health | May 11, 2017

3-D Mammography Changing the Face of Cancer Screening and Treatment

Global market research gives insight to the competitive mammography landscape

mammography exam

Photo courtesy of Hologic

Breast cancer is one of the leading causes of death of women worldwide. In Canada, according to the Canadian Cancer Society, one in every nine women is expected to develop breast cancer in her lifetime, and one in thirty will die from it. Though breast cancer rates were high relatively high in the 1990s, they decreased in the 2000s—and continue to remain much lower than they were in the 80s and 90s—thanks to the increased use of mammography. Mammography can detect early breast cancer in women experiencing no symptoms and is an essential tool and lifesaving measure. According to Infiniti Research, the global market for mammography devices and equipment will grow at a rate of more than 9 percent until 2020.

Infiniti Research has recently completed a market assessment on the mammography device market for a leading global manufacturer and supplier of diagnostic products, medical imaging systems, and surgical products. The purpose of this study was to help the client assess and analyze the competitive landscape for mammography devices.

 

Market Trends

Though 2-D mammography has long been an effective and affordable industry standard, 3-D mammography is becoming more popular. While 2-D mammography captures two static images of the breast, 3-D mammography takes multiple images of the breast, allowing for a more comprehensive and accurate picture, and reducing the risk of missing abnormalities due to image overlap. However, the benefits of 3-D mammography over 2-D have yet to be fully proven, and 3-D mammography is more expensive for uninsured patients. Another popular method involves combining 2-D and 3-D mammography, though this is currently very new. Some studies have suggested that 3-D mammography puts the patient at a higher risk for cancer from radiation, though this has not yet been confirmed.

 

Market Opportunities

Because the use of 3-D and combination 2-D and 3-D mammography is still relatively new and the risks associated with it are still largely unknown or unconfirmed, market intelligence is critical for vendors looking to enter this market. To keep their patients safe and establish themselves as reliable, vendors need to be up-to-date on market trends and developments, medical advancements and challenges, and how breast cancer incidence and treatment differs around the world.

In their latest assessment of the global mammography device market, Infiniti’s market intelligence analysts helped their client, a leading global manufacturer and supplier of diagnostic products, to gain an in-depth understanding of how the competitive landscape for mammography devices and equipment differed across the world, with special focus on target countries including the US, Germany, China, Great Britain, Australia, and France. Infiniti’s analysts researched and monitored the latest developments in the market through journals and whitepapers, and also conducted extensive interviews with stakeholders such as channel partners, business executives, and suppliers in order to develop a holistic overview of the market scenario.

 

You can view the complete study here: https://www.infinitiresearch.com/casestudy/competitive-intelligence-assessment-mammography-devices

Related Content

SmartCurve technology, a revolutionary breast imaging technology designed specifically for the curvature of the female breast to provide every woman with a more comfortable and accurate mammogram.
News | Mammography | September 14, 2018
Solis Mammography declared September Breast Wellness Month a
breast screening
News | Clinical Trials | September 13, 2018
Fewer and fewer women die from breast cancer in recent years but, surprisingly, the decline is just as large in the a
Lightvision near-infrared fluorescence imaging system
News | Women's Health | September 11, 2018
Shimadzu Corp.
Feature | Breast Imaging | September 07, 2018 | By JoAnn Pushkin
If you are confused about the conflicting advice surrounding mammography screening guidelines, welcome to the club.
Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...